Cannabis Stocks Face Fresh Delay as DEA Rescheduling Stalls
Separate reports on Canopy Growth and Green Thumb Industries describe the same holdup at the Drug Enforcement Administration slowing a long-promised regulatory shift.
Trump's push to reschedule marijuana federally remains stuck at the DEA, delaying a change that cannabis companies including Canopy Growth and Green Thumb Industries have been counting on for tax and banking relief.
BREAKING STORYBEARISH